LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY

被引：1
|
作者：
Mcinnes, I. [1 ]
Kato, K. [2 ]
Magrey, M. [3 ]
Merola, J. F. [4 ,5 ]
Kishimoto, M. [6 ]
Haaland, D. [7 ,8 ]
Chen, L. [2 ]
Duan, Y. [2 ]
Liu, J. [2 ]
Lippe, R. [9 ]
Wung, P. [2 ]
机构：
[1] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Scotland
[2] AbbVie Inc, Immunol, N Chicago, IL USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Harvard Med Sch, Dermatol & Rheumatol, Boston, MA 02115 USA
[6] Kyoto Univ, Sch Med, Dept Nephrol & Rheumatol, Tokyo, Japan
[7] McMaster Univ, Hamilton, ON, Canada
[8] Waterside Clin, Rheumatol & Clin Immunol Allergy, Barrie, ON, Canada
[9] AbbVie Deutschland GmbH Co KG, Immunol, Wiesbaden, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.799
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0081
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
    Baraliakos, Xenofon
    Ranza, Roberto
    Ostor, Andrew
    Ciccia, Francesco
    Coates, Laura C.
    Rednic, Simona
    Walsh, Jessica A.
    Douglas, Kevin
    Gao, Tianming
    Kato, Koji
    Song, In-Ho
    Ganz, Fabiana
    Deodhar, Atul
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [42] LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY
    Fleischmann, R.
    Song, I. H.
    Enejosa, J.
    Mysler, E.
    Bessette, L.
    Durez, P.
    Ostor, A.
    Swierkot, J.
    Song, Y.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 319 - 319
  • [43] Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
    Xenofon Baraliakos
    Roberto Ranza
    Andrew Östör
    Francesco Ciccia
    Laura C. Coates
    Simona Rednic
    Jessica A. Walsh
    Kevin Douglas
    Tianming Gao
    Koji Kato
    In-Ho Song
    Fabiana Ganz
    Atul Deodhar
    Arthritis Research & Therapy, 25
  • [44] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Nash, Peter
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27
  • [45] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Shaw, Tim
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny J.
    Mease, Philip J.
    RHEUMATOLOGY, 2022, 61
  • [46] Long-Term Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Burmester, Gerd
    Cohen, Stanley
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny
    Shaw, Tim
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3525 - 3527
  • [47] Long-Term Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    SWISS MEDICAL WEEKLY, 2022, 152 : 16S - 16S
  • [48] Sustained clinical efficacy and safety of adalimumab in patients with moderate to severe psoriatic arthritis: 2-year results from PSA study M02-537
    Mease, P. J.
    Genovese, M.
    Ritchlin, C. T.
    Van den Bosch, F.
    Wellborne, F.
    Birbara, C.
    Thomson, G.
    Perdok, R.
    Medich, J.
    Wong, R.
    Gladman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 419 - 419
  • [49] Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis
    Mahmood, Aysal
    Ali, Abraish
    Haider, Hoorain
    Zulfiqar, Beenish
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 118 : 152 - 154
  • [50] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
    Norito Katoh
    Yukihiro Ohya
    Hiroyuki Murota
    Masanori Ikeda
    Xiaofei Hu
    Kimitoshi Ikeda
    John Liu
    Takuya Sasaki
    Eliza M. Raymundo
    Henrique D. Teixeira
    Hidehisa Saeki
    Dermatology and Therapy, 2023, 13 : 221 - 234
12345